Zoetis Inc. (NYSE:ZTS – Get Free Report) shares were down 6.2% during mid-day trading on Friday after JPMorgan Chase & Co. lowered their price target on the stock from $130.00 to $115.00. Argus reissued a “hold” rating on shares of Zoetis in a report on Wednesday, May 27th. Also, Director Michael B. Mccallister acquired 3,000 shares of Zoetis stock in a transaction dated Monday, May 11th. Insiders have acquired 11,650 shares of company stock valued at $886,384 in the last 90 days. Zoetis Company Profile(Get Free Report)Zoetis Inc (NYSE: ZTS) is a global animal health company that develops, manufactures and markets a broad portfolio of products and services for companion animals and livestock.